FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34531411000001103: Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104439401000001118 Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104439501000001119 Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Is a Carfilzomib 30mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has active ingredient Carfilzomib true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has specific active ingredient Carfilzomib true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Is a Kyprolis true Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) 1 vial Has AMP True Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start